Article ; Online: Amantadine Treatment for People with COVID-19.
2020 Volume 51, Issue 7, Page(s) 739–740
Abstract: SARS-Cov-2, whose symptoms include difficulty swallowing, coughing, diarrhea, and breathing failure, has caused the loss of many lives around the world. In the absence of a vaccine or medication to help prevent or decrease the effects of the disease, we ... ...
Abstract | SARS-Cov-2, whose symptoms include difficulty swallowing, coughing, diarrhea, and breathing failure, has caused the loss of many lives around the world. In the absence of a vaccine or medication to help prevent or decrease the effects of the disease, we suggest that amantadine may reduce the effects of COVID-19. |
---|---|
MeSH term(s) | Amantadine/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; Humans ; SARS-CoV-2 |
Chemical Substances | Antiviral Agents ; Amantadine (BF4C9Z1J53) |
Keywords | covid19 |
Language | English |
Publishing date | 2020-06-12 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 1156844-6 |
ISSN | 1873-5487 ; 0188-4409 ; 0188-0128 |
ISSN (online) | 1873-5487 |
ISSN | 0188-4409 ; 0188-0128 |
DOI | 10.1016/j.arcmed.2020.06.009 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 1001: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.